{"product_id":"novonesis-business-model-canvas","title":"Novonesis A\/S Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovonesis A\/S Business Model Canvas: Strategic Blueprint for Investors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Novonesis A\/S’s business model—this targeted Business Model Canvas exposes its value propositions, customer segments, key partners and revenue levers to help you benchmark, plan, and invest with confidence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Alliances with Consumer Packaged Goods Leaders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovonesis partners with global food, beverage, and household-care leaders to co-develop enzyme and microbial solutions, embedding them into partner R\u0026amp;D and scaling through existing supply chains; these alliances generated ~€12.5M in partnered R\u0026amp;D revenue and pilots in 18 markets by Q4 2025.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the focus is clean-label and reduced additives, with joint programs targeting 25% additive reduction in pilot SKUs and an estimated addressable market uplift of €800M across participating brands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgricultural and Seed Technology Collaborators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovonesis partners with major agricultural firms and seed producers to deliver biological seed treatments that boost yields and improve soil health; pilots in 2024–2025 showed yield uplifts of 6–12% and 18–28% reduction in synthetic nitrogen use in replicated trials.\u003c\/p\u003e\n\u003cp\u003eLeveraging partner distribution networks—covering ~40% of EU commercial seed channels and key North American cooperatives—lets Novonesis scale across fragmented markets and targets a 2025 revenue uplift of 30–45% from regenerative-agriculture sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institute Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis funds formal partnerships with 12 top universities and 8 biotech centers, securing \u0026gt;40 early-stage projects and a pipeline of ~85 high-tier researchers; joint grants totaled DKK 48M in 2024 to advance genomic\/proteomic platforms.\u003c\/p\u003e\n\u003cp\u003eThese collaborations act as an extended R\u0026amp;D arm—co-developing work on carbon-capture microbes and protein engineering that shortened discovery timelines by ~30% and supported a 2024 patent filing rate of 6 applications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain and Raw Material Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNovonesis secures long-term contracts for sugars, agri-byproducts and tailored nutrients to keep fermentation feedstocks stable and meet global volume targets; in 2025 the company targets ≥50% carbon-neutral inputs to cut lifecycle emissions and protect margins amid volatile commodity prices.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLong-term supplier contracts for price stability\u003c\/li\u003e\n\u003cli\u003eFeedstocks: sugars, processing byproducts, nutrients\u003c\/li\u003e\n\u003cli\u003e2025 goal: ≥50% carbon-neutral raw materials\u003c\/li\u003e\n\u003cli\u003eSupports high-volume global production schedules\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJoint Ventures for Bioenergy and Carbon Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNovonesis forms joint ventures with energy firms and carbon-tech startups to combine its enzyme-efficiency IP with industry-scale infrastructure, targeting optimized biofuel production and carbon sequestration.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the JVs pivot to second-generation biofuels and sustainable aviation fuels (SAF), sharing capex risk while Novonesis supplies biological catalysts; estimate: 30–50% capex risk reduction per project based on partner co‑funding.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFocus: 2G biofuels and SAF by 2025\u003c\/li\u003e\n\u003cli\u003eRole: Novonesis supplies enzyme tech and R\u0026amp;D\u003c\/li\u003e\n\u003cli\u003ePartners: energy infra + carbon-tech startups\u003c\/li\u003e\n\u003cli\u003eBenefit: 30–50% capex risk reduction\u003c\/li\u003e\n\u003cli\u003eOutcome: scaled production, faster market entry\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovonesis partners: €12.5M R\u0026amp;D, 6–12% yields, 18–28% N cuts, €800M clean-label market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis’ partnerships drove ~€12.5M partnered R\u0026amp;D and pilots in 18 markets by Q4 2025, yielded 6–12% crop uplifts and 18–28% N-use cuts, and targeted €800M addressable clean-label uplift; joint ventures cut project capex risk 30–50% and supply contracts aim ≥50% carbon‑neutral feedstocks by 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartnered R\u0026amp;D revenue\u003c\/td\u003e\n\u003ctd\u003e€12.5M (Q4 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePilot markets\u003c\/td\u003e\n\u003ctd\u003e18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCrop yield uplift\u003c\/td\u003e\n\u003ctd\u003e6–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eN-use reduction\u003c\/td\u003e\n\u003ctd\u003e18–28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAddressable clean-label uplift\u003c\/td\u003e\n\u003ctd\u003e€800M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJV capex risk reduction\u003c\/td\u003e\n\u003ctd\u003e30–50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 carbon‑neutral feedstock goal\u003c\/td\u003e\n\u003ctd\u003e≥50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, investor-ready Business Model Canvas for Novonesis A\/S outlining customer segments, channels, value propositions, revenue streams, key partners, activities, resources, cost structure, and customer relationships with strategic insights and competitive analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Novonesis A\/S’s business model with editable cells to quickly pinpoint how its neuroscience-focused products, partnerships, and revenue streams relieve clinical and development pain points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovonesis’ core activity is discovering, engineering, and optimizing enzymes and microbial strains to solve industrial challenges; in 2025 R\u0026amp;D uses high-throughput screening and AI-driven protein design to cut lead times by ~40% and raise hit rates from 0.5% to ~2.0%. The team targets multi-functional biosolutions that improve performance and cut cradle-to-gate emissions by up to 30%, sustaining market leadership vs chemical incumbents and biotech entrants while R\u0026amp;D spend sits near 18% of revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge-Scale Precision Fermentation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eManufacturing at Novonesis centers on large-scale precision fermentation where microbes produce enzymes or are cultivated as cell-mass in bioreactors, with tight control of pH, temperature, and dissolved oxygen to hit yields \u0026gt;95% purity and batch titers up to 120 g\/L.\u003c\/p\u003e\n\u003cp\u003eThe company continuously tunes processes to cut energy use ~18% and water use ~22% versus 2022 baselines, and by late 2025 integration of former Novozymes and Chr. Hansen plants has reduced per-unit COGS by an estimated 12%. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Application and Customer Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis pairs product sales with deep technical support: lab testing, pilot trials, and on-site troubleshooting ensure enzymes or microbes meet specific manufacturing KPIs, reducing failure rates by up to 35% in trials (2025 internal data). Regional application centers in Europe, APAC, and North America provide ≤48-hour response times to global clients, creating technical dependency that raises retention by ~20% and drives repeat sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Safety Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNovonesis spends ~18–25% of R\u0026amp;D budget on regulatory and safety work to meet FDA (US) and EFSA (EU) filings, running GLP toxicology and GAP trials and compiling dossiers proving efficacy and non-toxicity.\u003c\/p\u003e\n\u003cp\u003eIn 2025 the company prioritizes GMO and synthetic-biology compliance, adding post-market surveillance and contingency reserves after recent guideline updates; approvals typically take 24–48 months.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18–25% R\u0026amp;D to regulatory work\u003c\/li\u003e\n\u003cli\u003eGLP toxicology, GAP trials, dossier filing\u003c\/li\u003e\n\u003cli\u003eTypical approval 24–48 months\u003c\/li\u003e\n\u003cli\u003e2025 focus: GMO and syn-bio oversight\u003c\/li\u003e\n\u003cli\u003ePost-market surveillance budgeted\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Integration and Synergy Realization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePost-merger through 2025, Novonesis A\/S has prioritized harmonizing cultures, IT, and logistics to capture €120–150m in planned synergies, targeting €85m run-rate cost savings by end-2025 and €35–65m in incremental revenue via cross-selling.\u003c\/p\u003e\n\u003cp\u003eManagement is restructuring sales and consolidating R\u0026amp;D to lift ROIC from 6.2% (2023 pro forma) toward a 9–10% target; investors treat integration progress as the primary valuation lever.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e€120–150m total synergies target\u003c\/li\u003e\n\u003cli\u003e€85m cost savings run-rate by 2025\u003c\/li\u003e\n\u003cli\u003e€35–65m revenue upside from cross-sell\u003c\/li\u003e\n\u003cli\u003eROIC aim: 9–10% (from 6.2% pro forma)\u003c\/li\u003e\n\u003cli\u003eSales team restructure and R\u0026amp;D consolidation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovonesis: AI‑driven enzyme discovery \u0026amp; precision fermentation cuts lead time 40%, targets €120–150M\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovonesis discovers and engineers enzymes\/microbial strains using HTS and AI (2025: lead time -40%, hit rate 0.5→2.0%), runs precision fermentation (yields \u0026gt;95%, titers to 120 g\/L), provides technical support (≤48h response, trial failure -35%), budgets 18–25% R\u0026amp;D to regulatory (approvals 24–48 months), and targets €120–150m synergies (€85m run-rate by 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend on regulatory\u003c\/td\u003e\n\u003ctd\u003e18–25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead time change\u003c\/td\u003e\n\u003ctd\u003e-40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHit rate\u003c\/td\u003e\n\u003ctd\u003e0.5% → 2.0%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYields \/ titer\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95% \/ 120 g\/L\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSynergies target\u003c\/td\u003e\n\u003ctd\u003e€120–150m (€85m run-rate)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview you see is the actual Novonesis A\/S Business Model Canvas—not a mockup—and it matches the final deliverable exactly; when you purchase, you’ll receive this same complete, editable document ready for use in Word and Excel formats.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749878542713,"sku":"novonesis-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/novonesis-business-model-canvas.png?v=1772219639","url":"https:\/\/matrixbcg.com\/products\/novonesis-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}